| Latest Forum Topics / Singapore eDev |
 Post Reply
|
|
Singapore eDev
|
|||||
|
wolverine23
Supreme |
24-Jun-2020 13:40
Yells: "Medical Bull 2020 !!!!!!!! = Internet Bull 2000 !!!!!!!!" |
||||
|
x 0
x 0 Alert Admin |
Don't miss. AGM egm
|
||||
| Useful To Me Not Useful To Me | |||||
|
guards80
Supreme |
24-Jun-2020 13:39
|
||||
|
x 0
x 0 Alert Admin |
Lai liao short. 66
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Sgvale
Supreme |
24-Jun-2020 13:39
|
||||
|
x 0
x 0 Alert Admin |
Wow..... not looking back already. 0.10 | ||||
| Useful To Me Not Useful To Me | |||||
|
polarinda
Master |
24-Jun-2020 13:38
|
||||
|
x 0
x 0 Alert Admin |
PnD in action | ||||
| Useful To Me Not Useful To Me | |||||
|
Shareskiat89
Elite |
24-Jun-2020 13:38
|
||||
|
x 0
x 0 Alert Admin |
yea... i kena scam 2 times alr. but looks like this time is real, already break 64.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
guards80
Supreme |
24-Jun-2020 13:36
|
||||
|
x 0
x 0 Alert Admin |
Done 65 let see can hold. | ||||
| Useful To Me Not Useful To Me | |||||
|
tofudidi
Supreme |
24-Jun-2020 13:36
|
||||
|
x 0
x 0 Alert Admin |
the best has yet to be
|
||||
| Useful To Me Not Useful To Me | |||||
|
guards80
Supreme |
24-Jun-2020 13:33
|
||||
|
x 0
x 0 Alert Admin |
Just rem few time news out chiong up then sell down.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
guards80
Supreme |
24-Jun-2020 13:32
|
||||
|
x 0
x 0 Alert Admin |
Yes better dont chase this.
|
||||
| Useful To Me Not Useful To Me | |||||
|
wenyen
Master |
24-Jun-2020 13:24
|
||||
|
x 0
x 0 Alert Admin |
SeD always sell off on news.. quite useless to chase unless break 65 or accumulate below 60 before that | ||||
| Useful To Me Not Useful To Me | |||||
|
wolverine23
Supreme |
24-Jun-2020 13:24
Yells: "Medical Bull 2020 !!!!!!!! = Internet Bull 2000 !!!!!!!!" |
||||
|
x 0
x 0 Alert Admin |
Still early.... 10 cents! | ||||
| Useful To Me Not Useful To Me | |||||
|
Shareskiat89
Elite |
24-Jun-2020 13:23
|
||||
|
x 0
x 0 Alert Admin |
i still skeptical lei, i rather dont chase. just now break 64 for a few seconds, after a while, 64 sell Q auto top up 2.5 millions
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
guards80
Supreme |
24-Jun-2020 13:22
|
||||
|
x 0
x 0 Alert Admin |
Will it break 65 strong resistance? Alway sell down from here | ||||
| Useful To Me Not Useful To Me | |||||
|
Shareskiat89
Elite |
24-Jun-2020 13:21
|
||||
|
x 0
x 0 Alert Admin |
they release annoucement, over their impact biomedical. in lab vitro testing, their equilever prove sucessful in preventing covid 19 virus from infecting hosts. but these are lab testing la, under controlled environment. and another products of theirs can disinfect covid19 virus on surfaces. overall is good news, but i very skeptical about SED already. everytime good news, chiong up, stuck at 64, then go down again. very hard for SED to stay above 60. really need 1 times good one to break.
|
||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
24-Jun-2020 13:20
|
||||
|
x 0
x 0 Alert Admin |
Key Point last para " Our intention in relation to the Covid-19 situation is to establish strong novel research data which will then be further developed and licensed to a major pharmaceutical company for integration and eventual deployment as treatments for diseases." Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance Singapore Exchange-listed Singapore eDevelopment Limited&rsquo s (&ldquo SeD&rdquo ) (Stock Code 40V) wholly owned subsidiary Impact Biomedical Inc. (&ldquo Impact Biomedical&rdquo ) announced today that they proved in vitro success of Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing. Impact Biomedical and Global Research and Discovery Group Sciences (&ldquo GRDG&rdquo ) contracted an independent university laboratory to challenge the compounds against the SARS-CoV-2 virus in their advanced Biosafety Level 3 containment facilities. Equivir is successful as a treatment as well as a prophylactic to protect cells against infection of the virus. Currently no known COVID-19 prophylactics have been developed. 3F Biofragrance is successful as a surface disinfectant by killing the virus in concentrations as low as 1/5000 after 15 seconds. These in vitro results confirm the predictions of advanced computational molecular docking which showed that Equivir and Linebacker had binding with high affinity to the COVID-19 helicase and protease. Equivir and Linebacker also cause transformational changes to the ACE-2 receptor which interferes with the ability of the virus to interact with the receptor and infect the host cell. Binding affinity for components of 3F Biofragrance was also observed in molecular docking. Equivir is patented and designed as a prophylactic to be deployed in a manner similar to a vitamin. It works by impeding virulence while also blocking multiple methods used by viruses to infect and replicate in host cells. Equivir treats and protects against diseases caused by not only SARS-CoV-2 but also other dangerous pathogens. Equivir has broad antiviral efficacy against multiple types of Influenza, Rhinovirus, Cholera, Ebola, and COVID-19. Linebacker was created to shadow the Panacea Project, a US Defense Advanced Research Projects Agency (DARPA) program to provide novel, multi-target therapeutics for unmet physiological needs. Linebacker is under continuing research against COVID-19 as it showed efficacy against SARS and MERS in previous laboratory testing. Linebacker is a patented universal therapeutic medication with demonstrated effectiveness in neurological diseases including Parkinson&rsquo s, many types of cancer, and multiple pathogens such as MRSA, E. coli, Cholera, A. baumannii, Influenza, SARS, MERS, Malaria, and Ebola. 3F Biofragrance was designed for the Open Air Defense Initiative, a strategy to protect large numbers of people where they gather such as containment areas, ports of entry, train stations, airports, convention centers, offices, schools, and hospitals. 3F Biofragrance technology also provides protection against mosquito-borne diseases such as Zika, Malaria and Dengue fever and is 10-fold more effective than DEET. 3F Antiviral Biofragrance is effective against E. coli, MRSA, Influenza, Rhinovirus, Tuberculosis, and COVID-19. 3F Biofragrance was developed in collaboration with Chemia Corporation (&ldquo Chemia&rdquo ), world-renowned for the development of fragrances and flavors for personal, household, and industrial applications. The combination of GRDG&rsquo s advanced scientific research and Chemia&rsquo s expert formulation and global scale production infrastructure makes this patent pending technology powerful and effective at protecting people Press Release &ndash Impact Biomedical Achieves Multiple COVID-19 Successes 24 June 2020 Page 2 of 3 from deadly pathogens and insects. &ldquo Chemia is proud to partner with GRDG to pioneer functional fragrances to not only enrich peoples&rsquo lives, but save them as well,&rdquo said Thomas A. Meyer, Vice-President of Innovation and Sustainability at Chemia. GRDG&rsquo s Chief Scientific Advisor is Dr. Roscoe M. Moore, Jr., the former United States Assistant Surgeon General and former Epidemic Intelligence Service Officer at Centers for Disease Control and Prevention or CDC. Dr. Moore said, &ldquo GRDG&rsquo s novel strategy of attacking diseases in multiple different ways is the future of effective pandemic response.&rdquo GRDG&rsquo s Chief Strategy Advisor is Lieutenant Colonel William H. Lyerly Jr., retired Career Senior Executive / Scientific Professional from the U.S. Department of Homeland Security and retired U.S. Army Medical Service Corps Officer. Lieutenant Colonel Lyerly also served as a senior official in the U.S. Department of Health and Human Services, the U.S. Agency for International Development, and the U.S. Executive Office of the President (White House). Lieutenant Colonel Lyerly said, &ldquo The validation of these solutions demonstrates GRDG&rsquo s skill in providing comprehensive solutions to global health threats.&rdquo Daryl Thompson, Director of Scientific Initiatives and founder of GRDG said, " I am happy to see that the 3F and Equivir biological countermeasures are performing as expected in independent efficacy testing. These positive results against the SARS-COV-2 virus now allow us to expeditiously move Equivir to clinical trials which we expect to be completed within the year. The 3F technology is ready for deployment in consumer products now.&rdquo Impact Biomedical&rsquo s technology solutions have been developed in strategic partnership with GRDG. Mr. Chan Heng Fai. &ldquo I am greatly encouraged with the results and the team&rsquo s contribution to this cause. We hope this will eventually prove to be beneficial to everyone and we look forward to more exciting discoveries.&rdquo said Mr. Chan. GRDG is in active engagement with large global corporations to position the technologies for rapid integration into multiple distribution routes to deploy these life-saving solutions worldwide. Our intention in relation to the Covid-19 situation is to establish strong novel research data which will then be further developed and licensed to a major pharmaceutical company for integration and eventual deployment as treatments for diseases. |
||||
| Useful To Me Not Useful To Me | |||||
|
machidrain
Veteran |
24-Jun-2020 13:16
|
||||
|
x 0
x 0 Alert Admin |
target 0.07 today | ||||
| Useful To Me Not Useful To Me | |||||
|
Superkilat
Elite |
24-Jun-2020 13:15
|
||||
|
x 0
x 0 Alert Admin |
What big news? Can share? | ||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
24-Jun-2020 13:14
|
||||
|
x 0
x 0 Alert Admin |
$0.065 followed by $0.07 tomorrow :)
|
||||
| Useful To Me Not Useful To Me | |||||
|
guards80
Supreme |
24-Jun-2020 13:12
|
||||
|
x 0
x 0 Alert Admin |
So fast alot taking profit. No power shortlist attack soon | ||||
| Useful To Me Not Useful To Me | |||||
|
wenyen
Master |
24-Jun-2020 13:10
|
||||
|
x 0
x 0 Alert Admin |
Sell on news, caution shortist at 62 | ||||
| Useful To Me Not Useful To Me | |||||